SCHEMBL22200437

SCHEMBL22200437

CC(C)n1c(=O)c(-c2ccc(N)nc2)nc2cnc(N)nc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 9/20 0.52
PIK3CA P42336 5/20 0.41
SYK P43405 1/20 0.38
ATM Q13315 1/20 0.37
RORC P51449 1/20 0.36
RICTOR Q6R327 1/20 0.36
RPTOR Q8N122 1/20 0.36
MAPKAP1 Q9BPZ7 1/20 0.36
MLST8 Q9BVC4 1/20 0.36
CSNK1E P49674 1/20 0.36
CLK1 P49759 1/20 0.36
CLK2 P49760 1/20 0.36
CLK3 P49761 1/20 0.36
GSK3B P49841 1/20 0.36
CDK5 Q00535 1/20 0.36
DYRK1A Q13627 1/20 0.36
CDK5R1 Q15078 1/20 0.36
DYRK2 Q92630 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
DYRK4 Q9NR20 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22200709 0.81 KDM5B (0.45) MTORPIK3CARICTORRPTORMAPKAP1
SCHEMBL22200463 0.80 MTOR (0.44) MTORPIK3CACLK4ALDH1A1CYP1A2
SCHEMBL22200749 0.78 PIK3CA (0.56) MTORPIK3CASYK
SCHEMBL25035488 0.77 ALDH1A1 (0.44) MTORRORCALDH1A1CYP1A2USP2
SCHEMBL22200634 0.77 MTOR (0.41) MTORRORCALDH1A1CYP1A2USP2
SCHEMBL22200802 0.77 MTOR (0.41) MTORPIK3CAALDH1A1CYP1A2USP2
SCHEMBL22200631 0.77 ERN1 (0.56)
SCHEMBL29356040 0.77 ERN1 (0.56)
SCHEMBL22191116 0.77 ERN1 (0.56)
SCHEMBL25035555 0.76 MTOR (0.42) MTORPIK3CARORCALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020142612-A1 PYRIDO-PYRIMIDINONE AND PTERIDINONE COMPOUNDS AS INHIBITORS OF ENDORIBONUCLEASE INOSITOL REQUIRING ENZYME I (IRE I ALPHA) FOR THE TREATMENT OF CANCER DISEASES. GENENTECH, INC. (US) 2020-07-09 WO disclosed